Literature DB >> 8588848

Hydrocephalus, corneal opacities, deafness, left ventricle hypertrophy, clinodactyly in an adolescent patient. A new syndrome associated with glucocerebrosidase deficiency.

E Erduran1, H Mocan, Y Gedik, R Kamaci, A Okten, O Değer.   

Abstract

We report a 12-year-old girl with an unusual phenotype of Gaucher disease type 3. Liver glucocerebrosidase activity was 20% of the normal. In addition to common manifestations such as hepatomegaly, she showed primary communicating hydrocephalus, corneal opacities, deafness, left ventricle hypertrophy, and clinodactyly of hands and feet. We suspect cardiomyopathy to be due to myocardiac infiltration with Gaucher cells, and corneal opacities to result from an accumulation of lipid-like inclusions into the posterior stromal keratinocytes. We were only able to find one previously published sibship disclosing similar features, which could allow the delineation of a new clinical variant of Gaucher disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588848

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  5 in total

Review 1.  Hearing loss in hydrocephalus: a review, with focus on mechanisms.

Authors:  David Satzer; Daniel J Guillaume
Journal:  Neurosurg Rev       Date:  2015-08-18       Impact factor: 3.042

Review 2.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

3.  Mitral valve prolapse and mitral insufficiency in two siblings with Gaucher's disease.

Authors:  S Celik; C Erdol; M Baykan; M Gokce; C Orem; I Durmus
Journal:  Images Paediatr Cardiol       Date:  2000-07

4.  Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study).

Authors:  Cecilia Lazea; Simona Bucerzan; Camelia Al-Khzouz; Anca Zimmermann; Ștefan Cristian Vesa; Ioana Nașcu; Victoria Creț; Mirela Crișan; Carmen Asăvoaie; Diana Miclea; Paula Grigorescu-Sido
Journal:  Diagnostics (Basel)       Date:  2021-05-29

Review 5.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.